Sign in
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary
Journal article   Peer reviewed

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary

Yehuda Handelsman, Paul S Jellinger, Chris K Guerin, Zachary T Bloomgarden, Eliot A Brinton, Matthew J Budoff, Michael H Davidson, Daniel Einhorn, Sergio Fazio, Vivian A Fonseca, …
Endocrine practice, Vol.26(10), pp.1196-1224
2020-10
PMID: 33471721

Abstract

Endocrinologists Anticholesteremic Agents Dyslipidemias - drug therapy Algorithms Dyslipidemias - epidemiology United States Cardiovascular Diseases - prevention & control Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Risk Factors Cardiovascular Diseases - epidemiology Consensus

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.68 Lipids
1.68.236 Statins
Web Of Science research areas
Endocrinology & Metabolism
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details